MTOR and hepatocellular carcinoma: Another comparable study found that AMSC-derived miR-199a-modified exosomes efficiently mediated the delivery of miR-199a to HCC cells, thus enhancing the chemosensitivity of HCC cells to doxorubicin in vivo and in vitro through mTOR pathway inhibition (Lou et al., 2020).